• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Catalog Number SBI05015008P
Device Problems Deflation Problem (1149); Detachment of Device or Device Component (2907)
Patient Problems Rupture (2208); Patient Problem/Medical Problem (2688)
Event Date 09/06/2017
Event Type  Injury  
Manufacturer Narrative
Device evaluation summary: the device was returned with the original pouch.A visual and a tactile inspection was carried out: the device was returned broken in three separate parts: luer with the shaft, that revealed a stretched portion in proximity of the welding; distal part of the balloon with a portion of the stretched underlying lumen; remaining part of the balloon with the tip.The tip was found damaged.Furthermore, dry blood and contrast agent was found on the device.The measured usable length of the returned device was 83.5 cm (the usable length foreseen in the lot release specifications for in.Pact admiral is 80 cm ± 2 cm).The device was flushed and an attempt to advance a 0.035¿ guide wire was performed, unsuccessfully: the guide wire got stuck in correspondence of the stretched portion of the shaft.
 
Event Description
The in.Pact admiral paclitaxel-eluting pta balloon was used to treat a calcified plaque lesion, with little calcification and moderate tortuosity, with 50% stenosis in the proximal mid superficial femoral artery.The artery diameter is 5mm, lesion length is 150mm.The balloon was inflated according to manufacturing specifications.Deflation time was relatively long due to repeated deflation methods.The balloon was completely deflated when using negative pressure, using suction of a 10ml syringe.The physician exchanged the sheath for a long 6fr to do the pta procedure unsuccessfully.There was no difficulty crossing the lesion with the in.Pact admiral, the balloon was completely deflated during the procedure.It was reported that difficulty was encountered removing the balloon from the sheath, the balloon and the sheath were removed together, resulting in a rupture to the common femoral artery, which required an open repair.It was reported that the patient has had a leg amputation post-procedure.It was reported that the amputation was not due to the procedure or use of the in.Pact admiral.The amputation was performed due to multiple stenosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7077162
MDR Text Key93555257
Report Number9612164-2017-01699
Device Sequence Number1
Product Code ONU
Combination Product (y/n)N
Reporter Country CodeSF
PMA/PMN Number
P140010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/24/2019
Device Catalogue NumberSBI05015008P
Device Lot Number0008232365
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/12/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/02/2017
Initial Date FDA Received12/01/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/24/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
Patient Age69 YR
-
-